Background and Purpose: An impairment of endothelial function is associated with vasospasm after subarachnoid hemorrhage. Oxyhemoglobin is considered to be a critical trigger in the pathogenesis of vasospasm. The present studies examined the direct effects of oxyhemoglobin on cultured endothelial cells from bovine carotid artery.
C erebral vasospasm is a major complication in patients with subarachnoid hemorrhage resulting from ruptured aneurysms. Despite many investigations, the pathogenesis of vasospasm is still a matter of discussion.1-4 It has been generally accepted that constituents of erythrocytes and substances produced during hemolysis of subarachnoid blood clots are closely associated with the induction of cerebral vasospasm. Among the substances found in the hemolysate, oxyhemoglobin is considered to play a key role in this process5-9; however, its precise mechanism of action is still controversial.7'10'1 It has recently been suggested that impairment of the vasodilatory activity of cerebral arteries after subarachnoid hemorrhage contributes to the pathogenesis of vasospasm.1213 One explanation for impaired vasodilation is that normal endothelial function is disrupted during the development of vasospasm. It is well documented that endothelial cell damage occurs after subarachnoid hemorrhage. [14] [15] [16] The present experiments distilled water, the purity of oxyhemoglobin was determined spectrophotometrically.7
Endothelial cells from bovine internal carotid artery were isolated by the method of Gospodarowicz et al. 17 Briefly, the Confluent endothelial cells were incubated under various conditions in medium containing 5% BCS. To investigate the effect of SOD or BPB on oxyhemoglobin-induced changes, cells were exposed to these compounds for 30 minutes before and during oxyhemoglobin treatment. The effect of EGTA was examined by adding it to the incubation medium only in the presence of oxyhemoglobin. After incubation for various periods of time, cell density was determined by using a dye uptake method described in detail elsewhere.18 Briefly, the cells were stained with 0.5% crystal violet (water: methanol, 4:1) for 15 minutes and then washed with water three times. Then the dye was eluted by 33% (vol/vol) acetic acid, and the absorbance at 600 nm was measured (model U-2000 spectrophotometer, Hitachi, San Jose, Calif.). SOD was denatured by titrating the protein to a pH of 10 and incubating at room temperature for 12 hours in the presence of a 10-fold excess of hydrogen peroxide followed by two-step dialysis.
Confluent endothelial cells were incubated with 1 mL of 0. (Figure 2 ), and this staining was specific; no positive staining was observed when incubations were performed in the absence of antibody. Almost all of the cultured cells were identified as endothelial cells because they incorporated Dil-Ac-LDL (1,1'-dioctadecyl-3,3,3',3'-tetramethyl-indocarbocyanine perchlorate). (Table 1) . The effects of two free fatty acids, palmitic acid and arachidonic acid, were tested on endothelial cells. Figure 4 shows the effect of fatty acid concentration on the cytotoxic response of the cells. Arachidonic acid inhibited cell growth in a dose-dependent manner, whereas palmitic acid had no effect at concentrations up to 100 uM. To investigate the mechanisms whereby oxyhemoglobin elicits cytotoxicity, the effects of indomethacin (cyclooxygenase inhibitor), SOD (free radical scavenger), EGTA (calcium ion chelator), and BPB (phospholipase A2 inhibitor19'20) on oxyhemoglobin-induced cytotoxicity were examined. BPB and SOD produced dose-dependent reductions in oxyhemoglobin-induced cytotoxicity (Table 1 ). EGTA and low-calcium medium also provided a substantial reduction in cytotoxicity. In contrast, indomethacin (10`M) had no protective effect. SOD inactivated with hydrogen peroxide also had no inhibitory effect (Table 1) .
The effect of oxyhemoglobin on release of radiolabel was studied in endothelial cell cultures treated with [ creased the release of radioactivity in a time-dependent manner ( Figure 5 ). The levels measured between 30 minutes and 5 hours after oxyhemoglobin addition were significantly higher than those of controls (p<O.O1). Figure 6 illustrates the dose dependence of the oxyhemoglobin-stimulated release of radiolabel from the cells.
One explanation for oxyhemoglobin-induced release of radiolabel is the activation of phospholipase A2 and the release of labeled arachidonic acid from phospholipids. To examine this idea, cultures were exposed to BPB, an inhibitor of phospholipase A2, before applying oxyhemoglobin. BPB at a concentration of 100 gM completely abolished the effects of oxyhemoglobin (Table 2). In contrast, indomethacin had no effect on the production of arachidonic acid in hemoglobin-treated endothelial cells ( Figure 6 ). cytotoxic effect is further supported by the observation that exogenously applied arachidonic acid is cytotoxic to the cells. The cytotoxic effect of arachidonic acid is dose dependent and not mimicked by palmitic acid, a structurally related free fatty acid. These observations suggest that the production of arachidonic acid and/or one of its metabolites by phospholipase A2 plays a critical role in damaging endothelial cells. This issue was examined by testing the effects of an inhibitor of cyclooxygenase (indomethacin). Cyclooxygenase is an enzyme responsible for producing prostaglandins from arachidonic acid, and increased production of prostaglandins has been observed in a variety of pathophysiological conditions. Pretreatment of endothelial cells with indomethacin, however, did not affect the extent of oxyhemoglobin-induced cytotoxicity.
Taken together, these observations indicate that arachidonic acid production by phospholipase A2 is a critical event in the endothelial cell toxicity, but that metabolism of arachidonic acid to prostaglandins does not appear to be a necessary step for cytotoxicity.
The participation of superoxide free radical and calcium in oxyhemoglobin-induced cytotoxicity is also indicated by the current studies. Scavenging of superoxide radicals by SOD or reducing calcium concentrations attenuated the cytotoxic effect of oxyhemoglobin on cultured endothelial cells. Further studies will be necessary to provide a more complete picture of the precise sequence of pathological events elicited by oxyhemoglobin in endothelial cells. Participation of the events described above in cerebrovascular pathology in vivo remains to be established. It is important to note, however, that recent immunocytochemical studies from this laboratory show that oxyhemoglobin can penetrate into the endothelial layer of the rabbit basilar artery after subarachnoid hemorrhage.30 Thus, oxyhemoglobin can gain access to the appropriate cellular target after subarachnoid hemorrhage. Taken together with the current findings, it is plausible that oxyhemoglobin derived from the lysis of a perivascular clot exerts direct and detrimental effects on endothelial cells in cerebral arteries.
Editorial Comment
Unlike most forms of stroke, hemorrhagic stroke has not decreased significantly in incidence over the last 40 years. In patients with hemorrhagic stroke or subarachnoid hemorrhage (SAH), one of the most enigmatic and life-threatening complications is vasospasm of the large cerebral arteries. In part, the morbidity and mortality associated with cerebral vasospasm can be attributed to our incomplete understanding of the pathophysiology of this clinical entity. The 
